UNITED THERAPEUTICS CORP Files SEC form 10-K, Annual Report
moreView todays social media effects on UTHRView the latest stocks trending across Twitter. Click to view dashboardSee who United is hiring next, click here to view […]
UTHR
United Therapeutics Corporation Reports 2013 Fourth Quarter And Annual Financial Results
[PR Newswire] – SILVER SPRING, Md., Feb. 25, 2014 /PRNewswire/ — Total Annual Revenues of $1.1 billion Annual Earnings per Share of $3.49 per Basic Share or $3.28 per Diluted Share Annual Non-GAAP Earnings of $10.88 … moreView todays social media effects on UTHRView the latest stocks trending across Twitter. Click to view dashboardSee who United is hiring next, click […]
Cempra (CEMP) Jumps: Stock Adds 6.1% in Session
moreView todays social media effects on UTHRView the latest stocks trending across Twitter. Click to view dashboardSee who United is hiring next, click here to view […]
United Therapeutics Corporation To Announce Fourth Quarter And Annual 2013 Financial Results Before Market Open On Tuesday, February 25, 2014
[PR Newswire] – SILVER SPRING, Md., Feb. 18, 2014 /PRNewswire/ — United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2013 financial results before market … moreView todays social media effects on UTHRView the latest stocks trending across Twitter. Click to view dashboardSee who United is hiring next, click here to view […]
PropThink: Oral Remodulin Rejection A Broader Problem; Continue To Sell
[ACN Newswire] – By Jake KingUnited Therapeutics Corporation (NASDAQ:UTHR) announced after hours on Tuesday that it’s application for an oral formulation of Remodulin (treprostinil) received a Complete Response Letter … moreView todays social media effects on UTHRView the latest stocks trending across Twitter. Click to view dashboard […]
